Type
. Anti-cyclic citrullinated peptide antibodies and rheumatoid factor sera titers in leprosy patients from Mexico. Rheumatology international. 2012;32(11):3531-6.
Type
. Leprosy and the natural selection for psoriasis. Medical hypotheses. 2012;78(1):183-90.
Type
. [Histopathology of leprosy]. Annales de dermatologie et de venereologie. 2011;138(11):777-81.
Type
. Evaluation of various cytokines elicited during antigen-specific recall as potential risk indicators for the differential development of leprosy. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology. 2012;31(7):1443-51.
Type
. Leprosy decline in Amazonas State, Brazil. Tropical medicine & international health : TM & IH. 2012;17(2):244-6.
Type
. A history of leprosy in Iran during the 19th and 20th centuries. Archives of Iranian medicine [Internet]. 2011;14(6):425-30. Available from: http://www.ams.ac.ir/AIM/NEWPUB/11/14/6/0014.pdf
Type
. Advances and hurdles on the way toward a leprosy vaccine. Human vaccines [Internet]. 2011;7(11):1172-83. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3323495/pdf/hv-7-1172.pdf
Type
. [Leprosy neuropathy: delayed diagnosis or a difficult diagnosis?]. Cadernos de saude publica [Internet]. 2011;27(10):2069. Available from: http://www.scielosp.org/pdf/csp/v27n10/20.pdf
Type
. Could leprosy reaction episodes be exacerbated by oral infections?. Revista da Sociedade Brasileira de Medicina Tropical [Internet]. 2011;44(5):633-5. Available from: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822011000500022&nrm=iso
Type
. Homology modeling and docking analyses of M. leprae Mur ligases reveals the common binding residues for structure based drug designing to eradicate leprosy. Journal of molecular modeling. 2012;18(6):2659-72.